Kumar SA - Search Results

1

APJ/apelin: A promising target for the treatment of retinopathy of prematurity.

Su J, Zhang Y, Kumar SA, Sun M, Yao Y, Duan Y. Su J, et al. Among authors: kumar sa. Drug Discov Today. 2022 Aug;27(8):2342-2352. doi: 10.1016/j.drudis.2022.05.004. Epub 2022 May 11. Drug Discov Today. 2022. PMID: 35561966 Review.

2

Current and future therapeutical approaches for COVID-19.

Duan Y, Yao Y, Kumar SA, Zhu HL, Chang J. Duan Y, et al. Among authors: kumar sa. Drug Discov Today. 2020 Aug;25(8):1545-1552. doi: 10.1016/j.drudis.2020.06.018. Epub 2020 Jun 20. Drug Discov Today. 2020. PMID: 32574697 Free PMC article. Review.

3

A hypothesis: Bitter taste receptors as a therapeutic target for the clinical symptoms of SARS-CoV-2.

Kumar SA, Cheng W. Kumar SA, et al. Pharmazie. 2021 Feb 25;76(2):43-54. doi: 10.1691/ph.2021.0840. Pharmazie. 2021. PMID: 33714279 Review.

4

A novel missense COL10A1 mutation: c.2020G>A; p. Gly674Arg linked with the bowed legs stature in the Schmid metaphyseal chondrodysplasia-affected Chinese lineage.

Chen Q, Wu SN, Chen YX, C SK, Zhang L, Wei HY, Kumar SA. Chen Q, et al. Among authors: kumar sa. Bone Rep. 2019 Dec 13;12:100240. doi: 10.1016/j.bonr.2019.100240. eCollection 2020 Jun. Bone Rep. 2019. PMID: 31921940 Free PMC article.

5

A novel stop-loss DAX1 variant affecting its protein-interaction with SF1 precedes the adrenal hypoplasia congenital with rare spontaneous precocious puberty and elevated hypothalamic-pituitary-gonadal/adrenal axis responses.

Yang H, Wei H, Shen L, Kumar C S, Chen Q, Chen Y, Kumar SA. Yang H, et al. Among authors: kumar sa, kumar c s. Eur J Med Genet. 2021 May;64(5):104192. doi: 10.1016/j.ejmg.2021.104192. Epub 2021 Mar 23. Eur J Med Genet. 2021. PMID: 33766795

6

Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2.

C SK, Kumar SA, Wei H. C SK, et al. Among authors: kumar sa. Toxicol Rep. 2020;7:1366-1372. doi: 10.1016/j.toxrep.2020.10.002. Epub 2020 Oct 8. Toxicol Rep. 2020. PMID: 33052306 Free PMC article.

7

Annotating the Role of ¹⁸F-FDG PET/CT in Fibromatoses: A Benign Masquerader of Malignancies-Is It Really an Advantageous Tool?

Kumar SA, Singh H, Kaman L, Nada R, Mittal BR. Kumar SA, et al. Nucl Med Mol Imaging. 2024 May;58(3):140-146. doi: 10.1007/s13139-024-00846-5. Epub 2024 Feb 14. Nucl Med Mol Imaging. 2024. PMID: 38633285

8

Design, synthesis and evaluation of new thiazolidin-4-ones as LPA₁ receptor antagonists for breast cancer therapy.

Bhagyalalitha M, Sr P, Prabhu A, Hs A, Kumar SA, Singh M, Pujar KG, Pujar GV. Bhagyalalitha M, et al. Among authors: kumar sa. Future Med Chem. 2024 Apr 5. doi: 10.4155/fmc-2023-0333. Online ahead of print. Future Med Chem. 2024. PMID: 38578146

9

FDG PET/CT in the Diagnosis and After Sunitinib Follow-up of Synchronous Base of Tongue and Thyroid Metastases From Renal Cell Carcinoma.

Kumar SA, Mittal BR, Kumar S, Singh H, Kumar R, Bal A. Kumar SA, et al. Clin Nucl Med. 2024 May 1;49(5):e208-e210. doi: 10.1097/RLU.0000000000005152. Clin Nucl Med. 2024. PMID: 38574256

10

From posttraumatic stress symptoms to suicidal ideation among military veterans: Pathways founded on meaning in life and gratitude.

Kumar SA, Taverna E, Borowski S, Smith BN, Vogt D. Kumar SA, et al. J Trauma Stress. 2024 Mar 25. doi: 10.1002/jts.23033. Online ahead of print. J Trauma Stress. 2024. PMID: 38527914

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

308 results

Search Page